This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ibio Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Martin Brenner: Innovator in Cancer Treatment
Introduction
Martin Brenner is a notable inventor based in Bryan, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Brenner holds a patent for an Anti-CD-25 antibody. This patent encompasses materials and methods for using polypeptides containing fragments and variants of the antibody that bind CD25 to treat cancer, either alone or in combination with other anti-neoplastic agents. His work in this area is crucial for advancing cancer therapies.
Career Highlights
Brenner is associated with iBio Limited, where he continues to push the boundaries of cancer research. His dedication to developing effective treatments showcases his commitment to improving patient outcomes.
Collaborations
He collaborates with talented individuals such as Tam Phuong and Cory Schwartz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Martin Brenner's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His contributions are paving the way for future advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile